Identification of the metabolites produced following Iris tectorum Maxim oral administration and a network pharmacology-based analysis of their potential pharmacological properties-Reference-Cited by-同舟云学术

Identification of the metabolites produced following Iris tectorum Maxim oral administration and a network pharmacology-based analysis of their potential pharmacological properties

Published:2021-04-07 Issue: Volume: Page:1-9
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Liu Jie¹,Xia Tian-Rui²

Affiliation:

1. Department of Pharmacy, Yinan People’s Hospital, Yinan, Shandong, China

2. Guangdong Yi Fang Pharmaceutical Co., Ltd, Foshan, China

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00498254.2021.1907473

Reference35 articles.

1. Isolation and Identification of Urinary Metabolites of Kakkalide in Rats

2. Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety

3. Identification of metabolites of tectoridin in-vivo and in-vitro by liquid chromatography-tandem mass spectrometry

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iristectorigenin A: Advances on Its Resources, Biological Activities, Molecular Mechanisms of Action, and Future Perspectives;Handbook of Dietary Flavonoids;2023

2. Insights into Irigenin: A Natural Isoflavonoid;Handbook of Dietary Flavonoids;2023

3. Medicinal Importance, Pharmacological Activities, and Analytical Aspects of an Isoflavone Glycoside Tectoridin;Current Nutrition & Food Science;2022-11

4. UGT1A1 and UGT1A9 Are Responsible for Phase II Metabolism of Tectorigenin and Irigenin In Vitro;Molecules;2022-06-26